The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.185
Bid: 0.17
Ask: 0.20
Change: 0.01 (5.71%)
Spread: 0.03 (17.647%)
Open: 0.175
High: 0.00
Low: 0.00
Prev. Close: 0.175
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Aug 2020 11:33

RNS Number : 7285W
Nuformix PLC
20 August 2020
 

Nuformix plc

("Nuformix" or the "Group")

 

 

Result of Annual General Meeting held on 20 August 2020

 

 

Cambridge, UK - 20 August 2020: Nuformix plc (LSE:NFX) announces that all resolutions proposed at its Annual General Meeting held today were duly passed on a poll, the results of which are set out below:

 

 

Votes For

% of Votes Cast

Votes Against

% of Votes Cast

Votes Withheld1

1

To receive the annual report and accounts for the year ended 31 March 2020

160,439,143

97.06

4,859,946

2.94

3,215,648

2

To approve the remuneration report contained within the Annual Report for the year ended 31 March 2020

160,409,517

97.05

4,871,780

2.95

3,233,440

3

To re-appoint Jo Holland as a director

160,421,351

97.06

4,859,946

2.94

3,233,440

4

To re-appoint Christopher Blackwell as a director

139,069,040

82.53

29,447,905

17.47

17,792

5

To appoint Karl Keegan as a director

139,057,206

82.52

29,459,739

17.48

17,792

6

To re-appoint Haysmacintyre as auditor of the Company

160,439,143

97.06

4,859,946

2.94

3,215,648

7

To authorise the directors to determine the remuneration of the auditor

160,421,351

97.05

4,877,738

2.95

3,215,648

8

To authorise the directors to allot shares

139,069,040

84.13

26,230,049

15.87

3,215,648

9

Authority to disapply pre-emption without restriction as to use (Special Resolution)

139,069,040

84.13

26,230,049

15.87

3,215,648

10

Authority to disapply pre-emption for acquisitions or specified capital investments (Special Resolution)

148,518,064

84.99

26,230,049

15.01

3,215,648

11

To authorise the Company to purchase its own shares (Special Resolution)

169,876,333

97.21

4,871,780

2.79

3,215,648

12

To authorise the Company to call a general meeting on not less than 14 clear days' notice (Special Resolution)

148,506,230

84.98

26,241,883

15.02

3,215,648

 

 

1 A vote withheld is not a vote under English law and is therefore not included in the calculation of votes for and against a resolution.

In accordance with Listing Rule 9.6.2, a copy of all resolutions passed as special business will shortly be available for inspection at the National Storage Mechanism document viewing facility at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Enquiries:

 

Nuformix plc

Roger Jones, Company Secretary

Fleur Wood, Investor Relations

Email: fleur.wood@nuformix.com

 

 

+44 (0)1223 627222

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGBBLFLBVLXBBF
Date   Source Headline
10th Mar 20217:00 amRNSProposed Placing to raise £1.565 million
8th Mar 202112:00 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResearch Results
22nd Feb 20213:45 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:01 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSAppointment of Broker
22nd Dec 20207:00 amRNSHalf-year Report
7th Dec 20207:00 amRNSAppointment of Chief Executive Officer
2nd Dec 20207:00 amRNSAppointment of Non-Executive Director
24th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
26th Oct 20202:16 pmRNSHolding(s) in Company
22nd Oct 20205:45 pmRNSHolding(s) in Company
22nd Oct 20204:16 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSPlacing and Strategic Update
24th Sep 20207:00 amRNSExclusive Option Agreement for NXP001
20th Aug 202011:33 amRNSResult of AGM
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20202:24 pmRNSResults Pre-clinical Pilot Study in IPF for NXP004
28th Jul 202012:14 pmRNSAnnual Report and Notice of AGM 2020
22nd Jul 20207:00 amRNSPreliminary Results for year ended 31 March 2020
1st Jul 202011:15 amRNSNotification of Major Holdings
22nd Jun 20207:00 amRNSBoard Change
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSBusiness Update
27th May 20207:00 amRNSNuformix and VistaGen Announce CNS Agreement
6th May 20203:30 pmRNSHolding(s) in Company
3rd Apr 20203:31 pmRNSHolding(s) in Company
30th Mar 20203:42 pmRNSNotiication of Major Share Holding
9th Mar 20204:42 pmRNSSecond Price Monitoring Extn
9th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSAppointment of Dr Karl Keegan
14th Feb 20204:41 pmRNSSecond Price Monitoring Extn
14th Feb 20204:35 pmRNSPrice Monitoring Extension
14th Feb 20202:05 pmRNSSecond Price Monitoring Extn
14th Feb 20202:00 pmRNSPrice Monitoring Extension
13th Feb 20204:40 pmRNSSecond Price Monitoring Extn
13th Feb 20204:35 pmRNSPrice Monitoring Extension
12th Feb 20204:10 pmRNSNotification of Major Holdings
5th Feb 20205:05 pmRNSOperational Update
5th Feb 20204:45 pmRNSResignation of Dave Tapolczay
5th Feb 20202:24 pmRNSDirector Dealing
5th Feb 20202:19 pmRNSNotification of Major Holdings
27th Jan 20207:00 amRNSMajor Shareholding Notification
27th Jan 20207:00 amRNSResignation of John Lidgey

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.